Femilon
Generic: Ethinyl Estradiol/Desogestrelby MSD Pharmaceuticals Pvt. Ltd.

Select pack size
About Femilon
Femilon is a combined birth control pill sold in India. Each tablet contains 0.15 mg (150 micrograms) of desogestrel, a progestogen, and 0.02 mg (20 micrograms) of ethinylestradiol, an oestrogen. Many combined pills contain 30 micrograms of ethinylestradiol; Femilon contains 20. These are the same doses as Organon's Mercilon in the UK. Femilon comes as a strip of 21 hormone tablets with no inactive tablets: one tablet a day for 21 days, then 7 days with no tablets. The carton and foil pouch in our product photo read "Desogestrel and Ethinylestradiol Tablets USP", desogestrel BP 0.15 mg and ethinylestradiol IP 0.02 mg per uncoated tablet, 21 tablets, with the Rx symbol and the MSD logo. We sell packs of 42 tablets (two cycles) and 63 tablets (three cycles), from $0.38 a tablet, or $8.00 a cycle, in the 63 pack before shipping.
Indian listings name different companies for Femilon. Truemeds and MediBuddy name Organon (India) Ltd, and Apollo Pharmacy names Organon India Ltd; PharmEasy gives Abbott India Ltd as the manufacturer name, with an address for N.V. Organon, Oss, the Netherlands. We have not found an Indian prescribing information for Femilon online, so this page uses the current labels for the same doses: the UK Mercilon label (Organon, revised October 2024), which also uses a 21 tablet strip with a 7 day break, and a current US label for desogestrel 0.15 mg with ethinyl estradiol 0.02 mg (Apotex, DailyMed, July 2026). We say which label each point comes from. The leaflet inside your Femilon pack is the one that applies to your tablets: read it before the first tablet.
A combined pill needs a check by a doctor, nurse or pharmacist before you start. High blood pressure, migraine with aura, a past blood clot and smoking at age 35 or over are common reasons a pill like Femilon is ruled out (our summary of the labels and the CDC guidance below). Please do not start Femilon, from us or anywhere else, until someone has checked these with you (see "Before you start" below).
Femilon at a glance
| Active ingredients | Desogestrel 0.15 mg and ethinylestradiol 0.02 mg per tablet (the carton and foil pouch in our product photo; Truemeds, PharmEasy, Apollo Pharmacy and MediBuddy listings) |
| Brand and maker | Femilon. Our product photo shows the MSD logo on the carton and foil pouch. Truemeds and MediBuddy name Organon (India) Ltd; Apollo Pharmacy names Organon India Ltd; PharmEasy names Abbott India Ltd. Truemeds gives the Netherlands as the country of origin; PharmEasy and Apollo Pharmacy give India |
| What it is for | Oral contraception (UK Mercilon label 4.1); "the prevention of pregnancy in women who elect to use this product as a method of contraception" (US label, Indications) |
| Regulatory status | The same doses are licensed, prescription only, in the UK (Mercilon, Gedarel 20/150). In the US the same tablet is sold only inside a 28 day pack that also holds 2 inactive tablets and 5 tablets of ethinyl estradiol 0.01 mg. We found no desogestrel pill with 20 micrograms of ethinylestradiol in Canada or Australia. Femilon, the Indian pack, is not registered with the FDA, MHRA, TGA or Health Canada |
| Usual dose from the label | One tablet a day for 21 days, then a 7 day tablet-free interval before the next strip (UK Mercilon label 4.2.1) |
| Missed tablet window | Up to 12 hours late: take it, no extra precautions. More than 12 hours: protection is reduced; see the 7 day rule below (UK Mercilon label 4.2.3) |
| Half-life | Etonogestrel (the active form of desogestrel) about 30 hours; ethinylestradiol about 24 hours (UK Mercilon label 5.2) |
| Packs | 42 tablets (two strips, two cycles) and 63 tablets (three strips, three cycles) |
| Price per tablet | $0.40 (42 pack) and $0.38 (63 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per cycle and per year
Prices are as of November 2026; the pack selector above shows the current price. One cycle is 21 tablets plus the 7 day break, which is 28 days, so a year is 13 cycles (364 days). The per cycle figures are our arithmetic.
| Order | Price | Per tablet | Cycles | Shipping | Per cycle with shipping |
|---|---|---|---|---|---|
| One 42 pack | $17.00 | $0.40 | 2 | $25 | $21.00 |
| One 63 pack | $24.00 | $0.38 | 3 | $25 | $16.33 |
| Three 63 packs and two 42 packs (one year) | $106.00 | $0.39 | 13 | $25 | $10.08 |
| Seven 63 packs | $168.00 | $0.38 | 21 | Free | $8.00 |
Before shipping, the 63 pack costs $8.00 a cycle and the 42 pack $8.50, so the two are close. The big difference is shipping: on a single pack, the $25 fee costs more than the tablets. A year's supply still pays $25 shipping because it comes to less than $149; an order of seven 63 packs (21 cycles) ships free and brings the cost to $8.00 a cycle. Only order a large supply once a doctor or nurse has agreed that Femilon suits you and you have used it for a few cycles without problems (our advice).
Compared with Mercilon, US packs and our other pills
| Femilon (ours) | US 28 day packs | Mercilon (UK) | Novelon (ours) | Loette (ours) | |
|---|---|---|---|---|---|
| Progestogen | Desogestrel 0.15 mg | Desogestrel 0.15 mg | Desogestrel 0.15 mg | Desogestrel 0.15 mg | Levonorgestrel 0.1 mg |
| Oestrogen | Ethinylestradiol 0.02 mg | Ethinyl estradiol 0.02 mg, then 0.01 mg on days 24 to 28 | Ethinylestradiol 0.02 mg | Ethinylestradiol 0.03 mg | Ethinylestradiol 0.02 mg |
| Pack | 21, no inactive tablets | 21 hormone tablets, 2 inactive, 5 ethinyl estradiol only | 21, then 7 days off | 21, no inactive tablets | 21, no inactive tablets |
| Status | Not registered in the US, UK, Canada or Australia | FDA approved generics, prescription only | Licensed, prescription only | Not registered in those countries | Not registered in those countries |
| Cost per cycle | $8.00 to $8.50 before shipping | About $4.90 at NADAC | Not priced here | $7.92 to $8.13 before shipping | $13.00 to $17.00 before shipping |
No US pill matches Femilon exactly. US packs such as Kariva, Azurette, Viorele, Pimtrea, Simliya and Volnea hold 21 tablets with the same doses as Femilon (desogestrel 0.15 mg and ethinyl estradiol 0.02 mg), then 2 inactive tablets, then 5 tablets of ethinyl estradiol 0.01 mg, with no break (US label, Description and Dosage and Administration). The original US brand, Mircette (Teva, NDA 020713), is listed as discontinued in Drugs@FDA, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons. Femilon has no extra low dose tablets: after 21 tablets you take nothing for 7 days.
NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. In the NADAC file as of 4 November 2026, Kariva, Azurette, Viorele, Pimtrea, Simliya and Volnea 28 day packs were all $0.17515 per tablet, effective 21 October 2026. Our arithmetic gives about $4.90 for a 28 day pack. So a US generic costs US pharmacies about $4.90 a cycle against our $8.00 to $8.50 before shipping. If you are in the US and have a prescription, compare US cash prices and your insurance cover first: a US generic is likely to be cheaper and is FDA approved, although its last 7 days differ from Femilon's.
In the UK, Mercilon (Organon) and Gedarel 20/150 are listed on emc with the same doses. In Canada, the Health Canada Drug Product Database lists desogestrel pills with 30 micrograms of ethinylestradiol (such as Marvelon) and a triphasic pill with 25 micrograms (Linessa), but we found none with 20 micrograms. In Australia, healthdirect lists Marvelon 28 and Madeline, both with 30 micrograms. Readers there who want this dose need to discuss the options with a doctor.
We have not seen a published study comparing Femilon with Mercilon or with US packs. Treat them as the same doses, not as proof of the same product, and do not mix tablets from different brands within one strip.
Femilon or Novelon: which one
We sell two desogestrel combined pills. Both contain 0.15 mg of desogestrel; they differ in the oestrogen dose.
| Product | Ethinylestradiol | UK equivalent | Schedule |
|---|---|---|---|
| Femilon | 20 micrograms | Mercilon | 21 tablets, then 7 days off |
| Novelon | 30 micrograms | Marvelon | 21 tablets, then 7 days off |
The US label says that, for any combination, the regimen prescribed "should be one which contains the least amount of estrogen and progestogen that is compatible with a low failure rate and the needs of the individual patient", and that "New acceptors of oral contraceptive agents should be started on preparations containing 0.035 mg or less of estrogen." Both Femilon and Novelon are below that level. A lower oestrogen dose does not make Femilon a low clot risk pill: the UK labels put Mercilon and Marvelon in the same clot risk band (see "Blood clots" below). Which dose suits you is a decision for your doctor or nurse; do not switch between the two on your own.
Before you start: the check you should not skip
The UK Mercilon label (4.4.2) says that before starting or restarting, a complete medical history including family history should be taken, pregnancy must be ruled out, blood pressure should be measured and a physical examination performed, guided by the contraindications and warnings. The US label allows the physical examination to be deferred until after starting "if requested by the woman and judged appropriate by the clinician". In our view, the minimum before your first strip of Femilon is a conversation with a doctor, nurse or pharmacist that covers:
- Blood pressure. Severe high blood pressure is a UK contraindication (4.3). The US label says women with a history of hypertension or hypertension-related diseases, or renal disease, "should be encouraged to use another method of contraception". The CDC's US Medical Eligibility Criteria (2024) rate combined pills category 3 (usually not recommended unless other more appropriate methods are not available or acceptable) at 140 to 159 systolic or 90 to 99 diastolic, and category 4 (an unacceptable health risk) at 160 systolic or 100 diastolic and above.
- Migraine. A history of migraine with focal neurological symptoms is a UK contraindication (4.3). The CDC rates migraine with aura category 4 for combined pills, and says "Aura is a specific focal neurologic symptom."
- Blood clots. A past deep vein thrombosis, pulmonary embolism or other clot, an inherited or acquired clotting disorder, or a parent or sibling who had a clot young (UK 4.3, 4.4).
- Smoking and age. The CDC says combined pills are usually not recommended for a person aged 35 or over who smokes fewer than 15 cigarettes a day, unless other methods are not available or acceptable (category 3), and that one who smokes 15 or more a day "should not use COCs because of unacceptable health risks, primarily the risk for myocardial infarction and stroke" (category 4). See the smoking warning below.
- Weight, age over 35, diabetes, liver disease, heart valve disease, lupus and any regular medicines (UK 4.3, 4.4, 4.5).
If you cannot see a clinician before you start, Femilon is not the right choice for you right now. A progestogen-only pill such as Cerazette (desogestrel 75 micrograms, no oestrogen) avoids the oestrogen risks, but it also needs a clinician's advice first.
How to take Femilon (21 tablet strip)
- First strip. The UK Mercilon label (4.2.2) says it is preferable to start on the first day of your period, in which case no extra precautions are needed. If your period began 2 to 4 days ago, start on day 5 and use extra precautions for the first 7 days. If it began more than 5 days ago, wait for your next period before starting.
- Every day. Take one tablet a day for 21 days, at about the same time each day, with some liquid as needed (UK 4.2.1).
- The 7 day break. After the 21st tablet, take no tablets for 7 days. A withdrawal bleed usually starts on day 2 or 3 of the break and "may not have finished before the next pack is started" (UK 4.2.1).
- Next strip. Start it after the 7 tablet-free days, whether or not your bleed has finished.
Switching from another 21 day combined pill: the UK label says finish the old pack and start Femilon the next day, with no gap; no extra precautions are needed. From a 28 day pill: start the day after the last active tablet and throw away the remaining inactive tablets (UK 4.2.2). From a progestogen-only pill: start on the first day of your period, or, if you have no periods, the day after stopping the mini pill with extra precautions for 7 days (UK 4.2.2). After a miscarriage or abortion: the UK label says start immediately, with no extra precautions needed.
US packs of this dose have 28 tablets and no break, and US labels also allow a Sunday start. Femilon has no inactive or low dose tablets, so the 7 days with no tablets replace them. If you are used to a 28 tablet pack, mark the restart day in your calendar. The UK label (4.2.2) also says rhythm methods should not be relied on for extra protection, because the pill disrupts the usual cycle signs such as temperature and cervical mucus.
If you miss a tablet
The UK Mercilon label (4.2.3), which uses the same 21 tablet strip as Femilon, says:
- Up to 12 hours late: "If the forgotten tablet is taken within 12 hours, no further precautions are necessary, further tablets should be taken at the usual time."
- More than 12 hours late: "If one or more tablets are forgotten for more than 12 hours, contraceptive protection will be reduced. The patient should take the last forgotten tablet, even if this means taking two tablets in one day, and then continue to take tablets at the normal time. Additional contraceptive precautions should be taken for the next seven days, and the patient should follow 'the 7-day rule'."
- The 7 day rule: keep taking your tablets as usual and use extra precautions for the next 7 days. If those 7 days run past the end of the current strip, start the next strip as soon as the current one is finished, with no break. The label explains that this "prevents an extended break in tablet taking which may increase the risk of the ovaries releasing an egg". You may then have no bleed until the end of the second strip, which the label says is not harmful.
The UK label lists extra precautions as not having sex, a cap plus spermicide, or a condom. The US label gives a different, tablet-count rule designed for its 28 tablet pack; follow the UK rule above or the leaflet in your Femilon pack. Our missed pill guide explains why 7 days of tablets matter; for Femilon, use the 12 hour figure from the label.
If you missed tablets and had sex in the days before, ask a pharmacist or doctor the same day whether you need emergency contraception (our advice). Our delivery takes 7 to 14 business days, so get emergency contraception from a local pharmacy. If you miss your withdrawal bleed after missed tablets, or miss two bleeds in a row, the UK label (4.4.4) says pregnancy must be ruled out before you carry on.
Vomiting or diarrhoea
The UK Mercilon label (4.2.3) says that if you vomit within 3 to 4 hours of a tablet, or have severe or prolonged diarrhoea, the missed tablet advice applies. To keep your usual schedule, take the extra tablet from another strip. Its 7 day rule also covers vomiting or diarrhoea lasting more than 12 hours: keep taking your tablets and use extra precautions for the next 7 days. The label adds that, unless diarrhoea is extremely severe, it does not affect absorption.
Medicines that can stop Femilon working
- UK Mercilon label (4.5.1): phenytoin, phenobarbital, primidone, bosentan, carbamazepine, rifampicin, rifabutin, and possibly oxcarbazepine, modafinil, topiramate, felbamate, griseofulvin, some HIV medicines (such as ritonavir and efavirenz) and St John's wort. Use a barrier method during treatment and for 28 days after stopping; if this runs past the end of a strip, start the next strip with no break. For long-term use of these medicines, the label says another method of contraception should be considered.
- US label (Precautions, Drug interactions): reduced efficacy and more breakthrough bleeding have been associated with rifampin, and "a similar association, though less marked, has been suggested with barbiturates, phenylbutazone, phenytoin sodium, carbamazepine and possibly with griseofulvin, ampicillin, and tetracyclines".
- Hepatitis C medicines: the UK label contraindicates Mercilon with ombitasvir/paritaprevir/ritonavir and dasabuvir, or with glecaprevir/pibrentasvir. It says switch to another method (such as a progestogen-only or non-hormonal method) before starting them, and restart 2 weeks after finishing. The US label contraindicates the pill with ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, says glecaprevir/pibrentasvir "is not recommended", and says the pill can be restarted approximately 2 weeks after finishing.
- Medicines that raise hormone levels (UK 4.5.1): strong or moderate CYP3A4 inhibitors such as ketoconazole, itraconazole, clarithromycin, fluconazole, diltiazem and erythromycin.
- Effects on other medicines: the pill may raise ciclosporin levels and lower lamotrigine levels (UK 4.5.1). The US label says the fall in lamotrigine "may reduce seizure control".
Tell your doctor or pharmacist about every medicine and herbal product you take, including short antibiotic or antifungal courses.
Side effects and bleeding
The UK Mercilon label (4.8) lists these possibly related effects in users of Mercilon or combined pills in general:
| Frequency (UK Mercilon label 4.8) | Effects |
|---|---|
| Common (1 in 100 or more) | Depressed mood, mood altered; headache; nausea, abdominal pain; breast pain, breast tenderness; weight increased |
| Uncommon (1 in 1,000 to 1 in 100) | Fluid retention; libido decreased; migraine; vomiting, diarrhoea; rash, urticaria; breast enlargement |
| Rare (under 1 in 1,000) | Hypersensitivity; libido increased; contact lens intolerance; venous and arterial thromboembolism; erythema nodosum, erythema multiforme; vaginal discharge, breast discharge; weight decreased |
| Not known | Worsening of symptoms of hereditary and acquired angioedema |
Bleeding between periods may occur, especially in the first months. The UK label (4.4.4) says irregular bleeding is only worth assessing after about three cycles; if it persists, or starts after regular cycles, other causes, including pregnancy, need to be checked.
Mood. The UK label lists severe depression, or a history of it, as a relative contraindication and says: "Depression can be serious and is a well-known risk factor for suicidal behaviour and suicide." Contact your doctor about mood changes or depressive symptoms, including shortly after starting.
Other effects the UK label names (4.4) include a small rise in blood pressure, which is rarely clinically relevant; chloasma (patchy dark skin on the face), so women prone to it should avoid sun and ultraviolet light; and a slightly higher chance of breast cancer being diagnosed in current users (relative risk 1.24 in a meta-analysis of 54 studies), with the excess gradually disappearing within 10 years of stopping. The label also notes rare benign, and even more rarely malignant, liver tumours. Women with diabetes should be carefully observed.
How well it works. The UK Mercilon label gives no pregnancy rate. The US patient leaflet says oral contraceptives "have a failure rate of about 1% per year when used without missing any pills" and that the typical failure rate is "less than 5% per year when women who miss pills are included".
Blood clots, heart attack and stroke
Every combined pill raises the risk of clots in the veins (deep vein thrombosis and pulmonary embolism), and of heart attack and stroke. Desogestrel pills, including those with 20 micrograms of ethinylestradiol, carry a higher clot risk than levonorgestrel pills in the regulators' review of the evidence.
| Women using | Clots in a year, per 10,000 women (UK Mercilon label 4.4) | EMA review, 2013 |
|---|---|---|
| No combined pill, not pregnant | About 2 | About 2 |
| A levonorgestrel pill | About 6 | About 5 to 7 |
| A desogestrel pill such as Femilon | Between 9 and 12 | About 9 to 12 |
- UK Mercilon label (4.4): "Products that contain levonorgestrel, norgestimate or norethisterone are associated with the lowest risk of VTE. Other products such as Mercilon may have up to twice this level of risk." The risk is highest in the first ever year of use, and there is some evidence it rises when a pill is restarted after a break of 4 weeks or more. VTE "may be fatal in 1-2% of cases". The UK figure of about 6 is the midpoint of 5 to 7 per 10,000 women-years. The UK label gives the 9 to 12 figure for CHCs containing desogestrel, with no separate figure for the 20 microgram dose.
- EMA review (2013): the European Medicines Agency concluded that the benefits of combined hormonal contraceptives in preventing unwanted pregnancies continue to outweigh their risks, and that the risk of clots in the veins with all of them is small. It found no evidence of differences in arterial clot risk between progestogens.
- US label (Warnings): "Several epidemiologic studies indicate that third generation oral contraceptives, including those containing desogestrel, are associated with a higher risk of venous thromboembolism than certain second generation oral contraceptives. In general, these studies indicate an approximate two-fold increased risk, which corresponds to an additional 1 to 2 cases of venous thromboembolism per 10,000 women-years of use. However, data from additional studies have not shown this two-fold increase in risk."
Risk rises with obesity (body mass index over 30), age (particularly over 35), a family history of clots, long immobility, surgery and the weeks after giving birth (UK 4.4). For planned surgery, the UK label advises stopping the pill at least four weeks before and not restarting until two weeks after full remobilisation, using another method meanwhile. It also names air travel of more than 4 hours as a possible risk factor, particularly with other risk factors. If you want the lowest clot risk at the same 20 microgram oestrogen dose, ask your doctor about a levonorgestrel pill such as Loette; it costs more per cycle from us than Femilon. Ovral L is a levonorgestrel pill with 30 micrograms. Our guide to birth control pills and blood clots explains the differences.
Smoking. The current US label for desogestrel 0.15 mg with ethinyl estradiol 0.02 mg (Apotex, July 2026) carries this boxed warning: "Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs, including Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP, are contraindicated in women who are over 35 years of age and smoke." The UK Mercilon label (4.4) says: "Women should be advised not to smoke if they wish to use a CHC. Women over 35 who continue to smoke should be strongly advised to use a different method of contraception." Our view follows the US label: if you are over 35 and smoke at all, do not take Femilon or any other combined pill.
When to get urgent help
Stop Femilon and call emergency services (911 in the US and Canada, 999 in the UK, 000 in Australia) for signs of a clot, heart attack or stroke. The UK Mercilon label (4.4) says to seek urgent medical attention and tell staff you take a combined pill; calling emergency services straight away is our advice. Signs the label lists include:
- swelling of one leg or foot, or along a vein in the leg; leg pain or tenderness that may be felt only when standing or walking; warmth, or red or discoloured skin, on the leg
- sudden unexplained shortness of breath or fast breathing; a sudden cough that may bring up blood; sharp chest pain; severe light-headedness or dizziness; a fast or irregular heartbeat
- chest pain, discomfort, pressure, heaviness, squeezing or fullness, or discomfort spreading to the back, jaw, throat, arm or stomach, with sweating, nausea, vomiting or dizziness
- sudden numbness or weakness of the face, arm or leg, especially on one side; sudden trouble walking, speaking or understanding; sudden confusion; sudden trouble seeing in one or both eyes; a sudden, severe or prolonged headache with no known cause; fainting
- blurred vision that gets worse or sudden loss of vision, which can be a clot in the eye
Also get urgent help for swelling of the lips, tongue or throat, trouble breathing, hives or a rash, which can be signs of a serious allergic reaction (our advice; the UK label lists hypersensitivity as a rare effect and the US label lists allergic rash). See a doctor promptly for yellow skin or eyes (the US label says the pill should be stopped if jaundice develops), upper abdominal pain or an enlarged liver (UK 4.4), or migraine that starts or gets worse, or headaches of a new pattern that are recurrent, persistent or severe (the US label says this requires stopping the pill and finding the cause). Tell staff you take desogestrel with ethinylestradiol and for how long.
Overdose. The UK label (4.9) says there have been no reports of serious harm from overdose; nausea, vomiting and slight vaginal bleeding may occur, and there is no antidote. If a child swallows tablets, call a doctor or poison line (our advice).
Who should not take Femilon
The UK Mercilon label (4.3) says combined pills should not be used with any of these, and should be stopped at once if one appears for the first time:
- a blood clot in a vein now or in the past (deep vein thrombosis, pulmonary embolism), or a known inherited or acquired clotting tendency such as factor V Leiden or antithrombin, protein C or protein S deficiency
- major surgery with long immobilisation, or several risk factors that make a clot likely
- a heart attack, angina, stroke or mini-stroke (TIA) now or in the past, or a known tendency to arterial clots such as antiphospholipid antibodies
- a history of migraine with focal neurological symptoms
- one serious arterial risk factor: diabetes with blood vessel symptoms, severe high blood pressure or a severe blood fat disorder; or several arterial risk factors
- pancreatitis linked to very high triglycerides, now or in the past
- severe liver disease until liver tests are normal again, or a liver tumour, benign or malignant
- known or suspected oestrogen-dependent cancer, such as some breast cancers
- endometrial hyperplasia, or vaginal bleeding that has not been diagnosed
- known or suspected pregnancy
- allergy to desogestrel, ethinylestradiol or any other ingredient
- the hepatitis C combinations named above
The US label also lists: cerebral vascular or coronary artery disease; current or past breast cancer; cholestatic jaundice of pregnancy or jaundice with earlier pill use; liver adenomas or carcinomas; and, in its boxed warning, women over 35 who smoke. The UK label also says women with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption "should not take medicine", because Mercilon contains lactose; we have not seen Femilon's ingredient list, so check the carton or ask your pharmacist.
Pregnancy. The UK label (4.6) says Mercilon "is not indicated for use during pregnancy" and to stop if pregnancy occurs; most studies have not found an increased risk of birth defects when a combined pill was taken by mistake in early pregnancy.
Breastfeeding and after a birth. The UK label (4.2.2) says breastfeeding mothers "should be advised not to use the combined pill since this may reduce the amount of breast-milk, but may be advised instead to use a progestogen-only pill (POP)." The US label says that, if possible, a nursing mother should use other forms of contraception "until she has completely weaned her child". For women who are not breastfeeding, the UK label says start 21 days after the birth, with extra precautions for 7 days if started later, and wait for the first period if you have had sex since the birth; the US label says it may be started 4 weeks after delivery in women who are not breastfeeding, and that the higher clot risk after giving birth must be considered.
Age. The UK label (4.2.4) says the safety and efficacy of desogestrel below 18 years "has not yet been established. No data are available." The US label says safety and efficacy "are expected to be the same for postpubertal adolescents under the age of 16 and for users 16 years and older", and that use before the first period is not indicated.
Sexually transmitted infections. Femilon does not protect against sexually transmitted infections, including HIV (UK 4.4.2; US label, Precautions). Use condoms for that.
Prescription and legal status
- India: the carton in our product photo carries the Rx symbol. Apollo Pharmacy lists Femilon as a prescription medicine, Truemeds says a prescription is required, and MediBuddy marks it Rx.
- US: 28 day packs with desogestrel 0.15 mg and ethinyl estradiol 0.02 mg plus ethinyl estradiol 0.01 mg tablets (Kariva, Azurette, Viorele and other generics) are prescription only. Femilon is not registered with the FDA, and the FDA says personal importation of unapproved medicines is illegal in most circumstances.
- UK: Mercilon (PL 00025/0598, Organon Pharma (UK) Limited) is a prescription only medicine; emc also lists Gedarel 20/150 with the same doses. Femilon is not authorised in the UK.
- Canada: the Drug Product Database lists desogestrel combined pills as prescription medicines, but we found none with 20 micrograms of ethinylestradiol, and no DIN for Femilon.
- Australia: desogestrel combined pills such as Marvelon 28 are Schedule 4 (prescription only medicine) (healthdirect). We found no 20 microgram desogestrel pill listed, and Femilon is not registered with the TGA.
Prescription rules exist for this pill because of the checks described above. See a doctor, nurse or pharmacist before you start, and check the rules where you live.
Buying genuine Femilon
The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have", and advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers Femilon, which is not authorised in the UK. When your order arrives, read the strip and carton: they should name Femilon, desogestrel 0.15 mg and ethinylestradiol 0.02 mg, 21 tablets, the company, a batch number and an expiry date. The company printed may be MSD or Organon, depending on the batch. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. A pill without the right dose could fail without any warning sign, so if you doubt a supply, use condoms as well and take a pregnancy test if a withdrawal bleed does not come (our advice). If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Femilon to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries. Shipping costs a flat $25 on orders under $149 and is free from $149. PharmEasy says store below 25°C in the original packaging, protected from moisture and light; Truemeds says store below 30°C; Apollo Pharmacy says 10°C to 25°C or below 30°C. The UK Mercilon label (6.4) says do not store above 25°C and keep the strips in their original pouches. Follow the carton. Order your next strips well before the current one runs out, so the 7 day break never runs long.
See our shipping page and refund policy.
Other pills we sell
- Novelon: the same 0.15 mg of desogestrel with 30 micrograms of ethinylestradiol, at $7.92 to $8.13 a cycle before shipping.
- Loette and Ovral L: levonorgestrel pills (20 and 30 micrograms of ethinylestradiol); the UK label puts levonorgestrel among the progestogens with the lowest clot risk.
- Yaz: drospirenone with 20 micrograms of ethinylestradiol; the EMA review puts drospirenone in the same clot risk band as desogestrel.
- Cerazette: a desogestrel progestogen-only pill with no oestrogen.
Changing pills is a decision to make with a doctor or nurse.
Related guides
Sources
- Mercilon Tablets, Summary of Product Characteristics, Organon Pharma (UK) Limited, PL 00025/0598, date of revision 7 October 2024 (emc, updated 19 October 2024): 2, 4.1 to 4.9, 5.1, 5.2, 6.1, 6.4, 6.5. emc
- Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.02 mg and ethinyl estradiol tablets USP 0.01 mg, US prescribing information and patient labeling, Apotex Corp., DailyMed setid 5a179f7b-a718-494f-8c97-ece34f356ca7, SPL version 1 (published 1 July 2026; text revised November 2025): boxed warning, Description, Indications and Usage, Contraindications, Warnings (thromboembolism, blood pressure, headache, hepatitis C), Precautions (physical examination, liver, drug interactions, nursing mothers, pediatric use), Adverse Reactions, Dosage and Administration, patient labeling. DailyMed
- European Medicines Agency. Combined hormonal contraceptives, Article 31 referral (PRAC and CHMP conclusions 2013; European Commission decision January 2014). EMA
- Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep 2024;73(No. RR-4):1 to 126 (PMID 39106314): smoking, hypertension and headache rows for combined hormonal contraceptives. PubMed
- US FDA, Drugs@FDA (openFDA): Mircette, NDA 020713, Teva, marketing status Discontinued, with a Federal Register determination that it was not discontinued or withdrawn for safety or effectiveness reasons; checked 6 November 2026.
- NADAC (National Average Drug Acquisition Cost), data.medicaid.gov, 2026 file, as of 4 November 2026: Kariva, Azurette, Viorele, Pimtrea, Simliya and Volnea 28 day tablets, $0.17515 per tablet, effective 21 October 2026.
- Health Canada Drug Product Database, search by active ingredient desogestrel (all products with 0.03 mg or 0.025 mg ethinyl estradiol); checked 6 November 2026.
- healthdirect Australia: desogestrel with ethinylestradiol (Madeline, Marvelon 28); Marvelon 28 Schedule 4, not PBS listed; checked 6 November 2026. healthdirect
- Indian pharmacy listings for Femilon (strip of 21 tablets): Truemeds, PharmEasy, Apollo Pharmacy and MediBuddy, read 6 November 2026; and our product photo of the carton and foil pouch.
- MHRA press release, 13 February 2026, on buying medicines online.
- US FDA, personal importation guidance.
Frequently asked questions
What is Femilon?
Femilon is a combined birth control pill sold in India. Each tablet contains 0.15 mg (150 micrograms) of desogestrel and 0.02 mg (20 micrograms) of ethinylestradiol, in a strip of 21 tablets with no inactive tablets. Our product photo shows the MSD logo on the carton and foil pouch; current Indian listings name Organon India or Abbott India. It is used to prevent pregnancy.
Is Femilon the same as Mercilon?
It has the same doses as Organon's Mercilon (desogestrel 150 micrograms and ethinylestradiol 20 micrograms) and, like the UK Mercilon pack, a 21 tablet strip with a 7 day break. We have not seen a published study comparing Femilon with Mercilon, so treat them as the same doses, not as proof of the same product.
Is there a US version of Femilon?
Not an exact one. US packs such as Kariva, Azurette and Viorele contain 21 tablets with the same doses as Femilon, but then 2 inactive tablets and 5 tablets of ethinyl estradiol 0.01 mg, taken with no break. Femilon has 21 tablets followed by 7 days with no tablets. The original US brand, Mircette, is listed as discontinued by the FDA, not for safety or effectiveness reasons.
How much does Femilon cost per cycle?
As of November 2026, a 42 tablet pack (two cycles) is $17 and a 63 tablet pack (three cycles) is $24, or $8.00 a cycle, before shipping; the pack selector shows the current price. Shipping is $25 under $149 and free from $149. In the US, Kariva type generics cost pharmacies about $4.90 a 28 day pack at NADAC (effective 21 October 2026; our arithmetic), so a US generic on prescription is likely to be cheaper.
How do I take Femilon?
The UK Mercilon label, for the same doses and strip, says start on the first day of your period, take one tablet a day at about the same time for 21 days, then take no tablets for 7 days. Start the next strip after the 7 tablet-free days, even if your bleed has not finished. If your period began 2 to 4 days ago, start on day 5 of your period and use extra precautions for the first 7 days; if it began more than 5 days ago, wait for your next period. Follow the leaflet in your pack.
What if I miss a Femilon pill?
The UK Mercilon label says that if you take the forgotten tablet within 12 hours, no further precautions are needed. If you are more than 12 hours late, protection is reduced: take the last forgotten tablet, even if that means two in one day, carry on at the usual time and use extra precautions for the next 7 days. If those 7 days run past the end of the strip, start the next strip with no break. If you had sex in the days before, ask a pharmacist about emergency contraception the same day.
Does the lower oestrogen dose mean a lower blood clot risk?
Not in the label figures. The UK Mercilon label says about 9 to 12 in 10,000 women on a desogestrel pill develop a clot in a year, against about 6 on a levonorgestrel pill and about 2 who use no pill and are not pregnant, and gives no separate figure for the 20 microgram dose. The EMA's 2013 review gives 9 to 12, 5 to 7 and 2. Ask your doctor about a levonorgestrel pill if you want the lowest clot risk among combined pills.
What are the common side effects of Femilon?
The UK Mercilon label lists depressed or altered mood, headache, nausea, abdominal pain, breast pain or tenderness and weight gain as common. Bleeding between periods can happen in the first months. Get urgent help for signs of a clot, heart attack or stroke, such as pain or swelling in one leg, sudden breathlessness, chest pain, sudden weakness on one side or sudden loss of vision.
Who should not take Femilon?
The UK Mercilon label says do not use it with a past or current blood clot or clotting disorder, a heart attack, angina or stroke, migraine with focal neurological symptoms, severe high blood pressure, diabetes with blood vessel damage, severe liver disease or a liver tumour, oestrogen-dependent cancer, undiagnosed vaginal bleeding, pregnancy, or certain hepatitis C medicines. The US label for the same tablet says combined pills are contraindicated in women who are over 35 and smoke. Breastfeeding mothers should not use it, according to the UK label. It does not protect against sexually transmitted infections.
Do I need a prescription for Femilon?
The Femilon carton carries the Rx symbol, and Indian pharmacies list it as prescription only (Apollo Pharmacy, Truemeds, MediBuddy). The same doses are prescription only in the UK (Mercilon) and, inside a 28 day pack, in the US. We found no 20 microgram desogestrel pill in Canada or Australia. Femilon itself is not registered with the FDA, MHRA, TGA or Health Canada. See a doctor, nurse or pharmacist for a blood pressure, migraine, clot and smoking check before you start.
How long does delivery take?
Standard delivery takes 7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is a flat $25 on orders under $149 and free from $149. Order your next strips well before the current one runs out, so the 7 day break never runs long, and never rely on our delivery for emergency contraception.
Medical References
- 1.Mercilon Tablets (desogestrel 150 micrograms, ethinylestradiol 20 micrograms), UK Summary of Product Characteristics, Organon Pharma (UK) Limited, PL 00025/0598 — 2024
- 2.Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.02 mg and ethinyl estradiol tablets USP 0.01 mg, US prescribing information, Apotex Corp. — 2026
- 3.European Medicines Agency: combined hormonal contraceptives referral (risk of blood clots by progestogen)
- 4.Nguyen AT et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep 2024;73(RR-4) (PMID: 39106314) — 2024
- 5.CMS National Average Drug Acquisition Cost (NADAC) 2026, file as of 4 November 2026 — 2026
- 6.healthdirect Australia: desogestrel with ethinylestradiol (Madeline, Marvelon 28)
- 7.US Food and Drug Administration: Personal Importation
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Femilon? Tell other buyers how it went.







